Choosing a hospital for cancer treatment abroad requires a different evaluation framework than choosing one for elective procedures. The stakes are higher, the treatment timelines are longer, the coordination between the international hospital and a home physician is more complex, and the consequences of a poor choice are more serious.
The hospitals in this guide have all been reviewed by the Medical Tourism Association through the Better by MTA verification process. Every institution covered holds JCI accreditation or equivalent internationally recognized certification, serves a high volume of international oncology patients, and has established infrastructure for managing the full clinical pathway of a visiting cancer patient from initial consultation through treatment, discharge, and coordination with home physicians.
Understanding what each hospital does particularly well, and which patient profiles each is best suited for, is the purpose of this guide.
Patients ready to connect with MTA-verified cancer centers can browse and submit a free inquiry at Better by MTA, the Medical Tourism Association's patient platform.
Apollo Hospitals Enterprise — Chennai, India
Why Apollo Matters for International Cancer Patients
Apollo Hospitals is India's largest private healthcare network and one of the most extensively studied hospital systems in Asia for international oncology outcomes. The group's flagship Chennai campus anchors Apollo's international oncology program and has treated patients from over 140 nationalities across virtually every cancer type and stage.
India's cost position for cancer treatment is among the most significant in the global medical tourism market. Chemotherapy regimens that cost $50,000 to $100,000 per cycle in the United States are available at Apollo for $5,000 to $20,000. Major surgical oncology procedures that run $80,000 to $200,000 in the US are completed at Apollo for $15,000 to $40,000. For the estimated 25 million Americans without meaningful health insurance coverage, and for international patients from countries where specific cancer treatments are unavailable or unaffordable, Apollo represents a genuinely life-changing access point.
The clinical program is comprehensive. Apollo's oncology department covers surgical oncology for all major solid tumors, medical oncology with access to standard chemotherapy, targeted therapy, and immunotherapy regimens following NCCN guidelines, radiation oncology including IMRT and SBRT, nuclear medicine, bone marrow transplantation, and a formal international second opinion program where patients can have their diagnosis and treatment plan reviewed remotely by Apollo's specialist teams before committing to travel.
Who Apollo Is Best Suited For
Apollo is the strongest choice for uninsured and underinsured US patients for whom cost is the determining factor alongside clinical quality. It is also the right choice for patients with breast, colorectal, lung, prostate, head and neck, and hematological cancers where Apollo's case volume and specialist depth are greatest. Patients from South Asia, the Middle East, and Africa who want the highest quality private oncology care within reach also represent a significant share of Apollo's international patient base.
Location: Greams Lane, 21, Greams Rd, Chennai, Tamil Nadu 600006, India
Accreditation: JCI Accredited
Key Services: Surgical Oncology, Medical Oncology, Radiation Oncology, Bone Marrow Transplant, Nuclear Medicine, Remote Second Opinion
Languages: English, Tamil, Hindi, and additional via translation services
View Apollo Hospitals on Better by MTA
Bumrungrad International Hospital — Bangkok, Thailand
Why Bumrungrad Matters for International Cancer Patients
Bumrungrad International in Bangkok is one of the most studied private hospitals in the world for international patient outcomes and is consistently cited in the medical tourism literature as the benchmark for what a high-quality international hospital looks like. The hospital treats patients from over 190 countries annually across every specialty, and its oncology department serves a substantial international patient population with access to the full range of modern cancer treatment modalities.
What distinguishes Bumrungrad for many international cancer patients is the combination of clinical quality with an international patient environment that Western patients find genuinely accessible. The hospital's physical environment, English-language care throughout, concierge-style international patient services, and the broader infrastructure of Bangkok as a city for extended stays create an experience that patients describe as substantially different from navigating a foreign healthcare system in an unfamiliar environment.
Thailand's cost position sits in the middle tier among the hospitals in this guide. Treatment costs are 50 to 70 percent lower than the United States but higher than India. For patients for whom India's distance or logistical complexity is a barrier, and who want Southeast Asia's most internationally established and comfortable hospital environment, Bumrungrad is the natural choice.
The hospital offers surgical oncology across all major tumor types including robotic-assisted and minimally invasive approaches, medical oncology following standard international protocols, radiation oncology, cancer screening programs, and comprehensive diagnostics. Bumrungrad's imaging department is one of the most equipped in Southeast Asia, which matters for patients whose treatment requires continuous high-quality diagnostic monitoring.
Who Bumrungrad Is Best Suited For
Bumrungrad is best suited for patients from Europe, North America, and the Middle East who want Southeast Asia's most internationally oriented hospital environment alongside strong oncology clinical capability. It is particularly well positioned for patients combining cancer treatment with follow-up care across a longer stay, for patients who want the most comfortable patient experience in the region, and for patients from countries in Asia and the Pacific for whom Bangkok is a natural travel hub.
Location: 33 Soi Sukhumvit 3, Sukhumvit Road, Bangkok 10110, Thailand
Accreditation: JCI Accredited
Key Services: Surgical Oncology, Medical Oncology, Radiation Oncology, Minimally Invasive Cancer Surgery, Cancer Screening, Comprehensive Diagnostics
Languages: English, Thai, Arabic, Japanese, and additional via international team
View Bumrungrad International Hospital on Better by MTA
Humanitas Research Hospital — Milan, Italy
Why Humanitas Matters for International Cancer Patients
Humanitas Research Hospital near Milan occupies a specific and important position in the international cancer care landscape that no other hospital in this guide replicates. It is not primarily a medical tourism destination in the traditional sense. It is a university-affiliated research hospital with an active clinical trials program, peer-reviewed publication output in the world's leading oncology journals, and a clinical care program that operates at the frontier of what European oncology standards define as best practice.
The hospital is affiliated with the University of Milan and its research teams publish extensively in journals including the Lancet Oncology, Journal of Clinical Oncology, and Annals of Oncology. This active research output means that certain patients, particularly those with rare cancers, cancers with unusual molecular profiles, or cancers where standard treatment has been exhausted, may have access to clinical trials and investigational protocols at Humanitas that are not yet available in standard care at their home institutions.
From a cost perspective, Humanitas is competitive relative to private oncology care in Northern Europe and the United Kingdom, while offering access to an institution whose research credentials most European private hospitals cannot match. For North American patients, it is priced above India and Thailand but offers something different: access to European academic oncology at a research institution with internationally published depth in specific cancer types.
The clinical program covers surgical oncology including robotic surgery, medical oncology, radiation oncology, and importantly a multidisciplinary tumor board process where complex cases are reviewed by teams of specialists whose combined expertise produces treatment recommendations that no single specialist working alone could generate.
Who Humanitas Is Best Suited For
Humanitas is best suited for patients with complex or rare cancers who want access to a research institution's clinical trials pipeline, for European patients seeking the highest level of private academic oncology care, and for patients who have specific reasons to prefer European treatment standards. It is also well positioned for patients whose cancer type falls within Humanitas's areas of published research concentration, where the clinical team's depth in that specific domain is greater than at a general oncology hospital.
Location: Via Alessandro Manzoni 56, 20089 Rozzano, Milan, Italy
Accreditation: JCI Accredited, University of Milan affiliated
Key Services: Surgical Oncology, Robotic Surgery, Medical Oncology, Radiation Oncology, Clinical Trials, Multidisciplinary Tumor Board
Languages: English, Italian, and additional via international patient team
View Humanitas Research Hospital on Better by MTA
King Faisal Specialist Hospital and Research Centre — Riyadh, Saudi Arabia
Why King Faisal Matters for International Cancer Patients
King Faisal Specialist Hospital and Research Centre is Saudi Arabia's foremost medical institution and one of the most respected specialist hospitals in the Middle East and North Africa region. The hospital's Research Centre designation reflects genuine research activity: active clinical trials programs, a bone marrow transplant program that is among the most established in the region, and specialist depth in cancer types that are epidemiologically prevalent in the MENA population.
For patients from across the Middle East, the Gulf states, North Africa, and South Asia, King Faisal represents the highest level of oncology care available within the region without traveling to Europe or North America. The hospital's international patient infrastructure, Arabic and English language care, and cultural familiarity for patients from the region make it a natural first choice for patients who prefer treatment within the broader MENA context.
The hospital's bone marrow transplant program is particularly noteworthy. For patients with hematological malignancies including leukemia, lymphoma, and multiple myeloma, King Faisal's transplant program has decades of accumulated experience and published outcomes comparable to leading programs globally.
Who King Faisal Is Best Suited For
King Faisal is the strongest choice for patients from the MENA region seeking the highest level of specialist oncology care, for patients with hematological malignancies requiring bone marrow transplantation, and for patients with cancer types where King Faisal's research programs have developed specific clinical depth. It is also a compelling option for patients who want world-class oncology care delivered within a culturally familiar environment.
Location: Riyadh, Saudi Arabia
Accreditation: JCI Accredited
Key Services: Full spectrum oncology, Bone Marrow Transplant, Pediatric Oncology, Research Oncology, Clinical Trials
Languages: Arabic, English
View King Faisal Specialist Hospital on Better by MTA
King's College Hospital Dubai — Dubai, UAE
Why King's College Hospital Dubai Matters for International Cancer Patients
King's College Hospital Dubai brings the brand, clinical governance standards, and physician training pathways of one of the United Kingdom's most respected NHS teaching hospitals to Dubai's healthcare infrastructure. For patients who specifically want access to King's clinical standards and treatment protocols, this is the only way to access them outside of London.
The hospital's position in Dubai gives it specific advantages for a defined patient population. Patients from the UAE, the Gulf states, the broader Middle East, and East Africa for whom Dubai is a more accessible destination than London or other European cities can access King's-standard oncology care without the long-haul travel that London requires. For UK patients themselves, some find that accessing King's-affiliated care in Dubai is faster and more flexible than navigating the NHS system for certain cancer treatment pathways.
King's College Hospital Dubai offers medical oncology, surgical oncology, and cancer diagnostics, and runs a second opinion program that can be initiated for international patients who want a King's-affiliated team to review their diagnosis and proposed treatment plan before committing to any course of action.
Who King's College Hospital Dubai Is Best Suited For
King's College Hospital Dubai is best suited for patients from the Gulf region who want access to UK-affiliated clinical standards without traveling to London, for UK patients seeking faster access to King's-standard care in a private setting, and for patients from East Africa and South Asia for whom Dubai is a more accessible destination than European alternatives.
Location: Dubai Hills, Dubai, United Arab Emirates
Affiliation: King's College Hospital London
Key Services: Medical Oncology, Surgical Oncology, Cancer Diagnostics, International Second Opinion Program
Languages: English, Arabic, and additional via international team
View King's College Hospital Dubai on Better by MTA
Burjeel Medical City — Abu Dhabi, UAE
Why Burjeel Medical City Matters for International Cancer Patients
Burjeel Medical City in Abu Dhabi is one of the UAE's most comprehensive private medical institutions, operating a dedicated cancer center within a purpose-built multi-specialty hospital that serves both Abu Dhabi's residential population and a significant international patient base from South Asia, Africa, and Europe.
The cancer center's scope is broad, covering surgical oncology, medical oncology, radiation oncology with modern linear accelerator technology, nuclear medicine, and bone marrow transplantation. Abu Dhabi's healthcare regulatory environment, governed by the Abu Dhabi Department of Health, maintains standards that are among the most rigorous in the region and provides patients with institutional oversight comparable to leading European health authority frameworks.
Burjeel's positioning within Abu Dhabi is complementary to King's College Hospital Dubai's positioning in Dubai. Patients who prefer Abu Dhabi as a destination, or whose specific clinical needs are better matched to Burjeel's specialist capabilities, have a genuinely strong option within the UAE market.
Who Burjeel Medical City Is Best Suited For
Burjeel is best suited for patients from South Asia, Africa, and the broader MENA region seeking Western-standard oncology care at Abu Dhabi cost levels, for patients needing bone marrow transplantation within the UAE, and for patients who want a comprehensive multi-specialty hospital environment where oncology is supported by the full range of specialist disciplines within the same institution.
Location: Mohamed Bin Zayed City, Abu Dhabi, UAE
Accreditation: JCI Accredited
Key Services: Surgical Oncology, Medical Oncology, Radiation Oncology, Nuclear Medicine, Bone Marrow Transplant
Languages: English, Arabic, Hindi, and additional via international team
View Burjeel Medical City on Better by MTA
How to Choose the Right Hospital for Your Cancer Treatment Abroad
Matching a patient to the right hospital requires honest evaluation of several variables simultaneously.
If cost is the primary driver and clinical quality at JCI-accredited standards is the requirement, Apollo Hospitals in India is the most financially accessible option in this guide by a substantial margin.
If the international patient experience and comfort of the hospital environment is important alongside strong oncology capability, Bumrungrad in Bangkok is the benchmark for what that looks like in Asia.
If you have a rare cancer, an unusual molecular profile, or want access to clinical trials, Humanitas in Milan is the only institution in this guide with an active research program and peer-reviewed publication output that gives patients access to the frontier of oncology knowledge rather than standard care alone.
If you are from the MENA region and want the highest level of specialist care within the region, King Faisal in Riyadh and Burjeel Medical City in Abu Dhabi are the strongest options, with King Faisal having particular depth in hematological malignancies and transplant programs.
If you specifically want access to UK-affiliated clinical standards outside of London, King's College Hospital Dubai is the only option in this guide that delivers that.
All six hospitals are accessible through Better by MTA's free inquiry system. One inquiry reaches the right institution for your specific situation.
Use an MTA Verified provider for all international cancer care considerations. Every hospital in this guide has been reviewed by the Medical Tourism Association. Connect through Better by MTA.
An Important Note on Medical Advice
Nothing in this guide constitutes medical advice or a recommendation for any specific treatment or hospital for any individual patient. All cancer treatment decisions must be made in consultation with your current oncologist. This guide is for educational purposes to help patients understand which MTA-verified international hospitals serve oncology patients and what each does best.
Ready to Connect With an International Cancer Center
Better by MTA connects you with MTA-verified oncology hospitals worldwide. One free inquiry, no obligation, no intermediary fees.
Start My Free Cancer Care Inquiry
Browse All Verified Oncology Hospitals on Better by MTA
By Jonathan Edelheit, CEO and Co-Founder, Medical Tourism Association. Last updated May 2026.
.png)
